Our Clinical Trial Experience With Ebola Virus Disease

Since 1976, Ebola virus disease outbreaks have primarily occurred in eleven countries: Democratic Republic of the Congo, Gabon, Guinea, Liberia, Mali, Nigeria, Republic of Congo, Sierra Leone, Sudan and Uganda. Although it is generally rare, it is often fatal, with death rates ranging from 25 to 90% in past outbreaks (average case fatality rate, 50%). No treatment or vaccine is currently approved, but there are several promising vaccines and treatments under development.
Thumbnail_Indication_Ebola

Related Resources

Indication Overview

Our Clinical Trial Experience With Tuberculosis

Indication Overview

Our Clinical Trial Experience With HIV

Indication Overview

Our Clinical Trial Experience With Malaria

Brochure

Our Experience in sub-Saharan Africa

Brochure

Full-Service Global Support for COVID-19 Studies

Brochure

About FHI Clinical

Indication Overview

Our Clinical Trial Experience With Oncology

Video

Project Profile: COVID-19 Study in Ghana